Plan B Pioneers OTC “Pharmacy Counter” Approval, Dual-Status Marketing
This article was originally published in The Tan Sheet
FDA's decision to approve emergency contraceptive Plan B for over-the-counter sale to women age 18 and older cracks open the door on a pharmacy-only, behind-the-counter model for nonprescription drug sales
You may also be interested in...
HRA expects to file an NDA for ellaOne in the U.S. by end of year.
FDA Commissioner Andrew von Eschenbach will return to Texas upon resigning his post Jan. 20, leaving a legacy that includes restarting discussions on whether a third class of drugs is needed
The safety record of emergency contraceptive Plan B supports removing age restrictions on sales of the product, according to Rebekah E. Gee, the lead researcher behind a survey on access to the drug and an advocate for women's access to reproductive medicine